JBIO vs INVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

JBIO

30.2
AI Score
VS
INVA Wins

INVA

50.4
AI Score

Investment Advisor Scores

JBIO

30score
Recommendation
AVOID NEW MONEY

INVA

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JBIO INVA Winner
Forward P/E 0 8.5616 Tie
PEG Ratio 0 2.8528 Tie
Revenue Growth 0.0% -1.6% JBIO
Earnings Growth 0.0% 590.4% INVA
Tradestie Score 30.2/100 50.4/100 INVA
Profit Margin 0.0% 44.1% INVA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD INVA

Relative Price Performance (Last 90 Days)

JBIO 1M: +18.1% · 3M: -35.8% INVA 1M: -9.5% · 3M: -10.5%

Current Technical Phase

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.2 · Price: $15.87

INVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $18.97

Fundamentals Snapshot

Metric JBIO INVA
Market Cap — —
Forward P/E -6.0 8.8
Trailing P/E — 8.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 0.8%
Operating Margin 0.0% 0.4%
EPS -1.92 2.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.